FDA Panel Backs Innoviva ' s Drug for Multidrug-Resistant Bacterial Infections FDA Panel Backs Innoviva ' s Drug for Multidrug-Resistant Bacterial Infections

The panel on Monday unanimously voted in favor of Innoviva ' s experimental antibiotic in the treatment of serious bacterial infections, typically associated with hospitalizations, the company said.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news